These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 29211320)
1. Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology. Poon DM; Chan CK; Chan TW; Cheung FY; Kwong PW; Lee EK; Leung AK; Leung SY; Ma WK; So HS; Tam PC; Ho LY BJU Int; 2018 May; 121(5):703-715. PubMed ID: 29211320 [TBL] [Abstract][Full Text] [Related]
2. Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology. Ma WK; Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Kwong PW BJU Int; 2019 Aug; 124(2):221-241. PubMed ID: 30653801 [TBL] [Abstract][Full Text] [Related]
3. Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer-2019 Updates. Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Kwong PW; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Ma WK Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():12-26. PubMed ID: 33860645 [TBL] [Abstract][Full Text] [Related]
4. Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology 2019. Poon DM; Chan CK; Chan K; Chu WH; Kwong PW; Lam W; Law KS; Lee EK; Liu PL; Sze HC; Wong JH; Chan ES Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():27-38. PubMed ID: 33860644 [TBL] [Abstract][Full Text] [Related]
5. Management of advanced prostate cancer in Hong Kong: Insights from an APCCC-Derived survey. Poon DM; Ma WK; Chan TW; Ho FK; Ho LY; Leung AK; Leung SY; Sze HC; Kwong PW; Chan ES Asia Pac J Clin Oncol; 2019 Oct; 15 Suppl 6():8-13. PubMed ID: 31642191 [TBL] [Abstract][Full Text] [Related]
6. Use of biologics for inflammatory bowel disease in Hong Kong: consensus statement. Leung WK; Ng SC; Chow DK; Lao WC; Leung VK; Li MK; Hui YT; Ng SS; Hui AJ; Lai ST; Lam JT; Poon JT; Chan AO; Yuen H; Wu JC; ; Hong Kong Med J; 2013 Feb; 19(1):61-8. PubMed ID: 23378357 [TBL] [Abstract][Full Text] [Related]
7. Recommendations for the management of advanced and metastatic renal cell carcinoma: joint consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology. Poon DMC; Chan CK; Chan K; Chu WH; Kwong PWK; Lam W; Law KS; Lee EKC; Liu PL; Sze HCK; Wong JHM; Chan ESY Hong Kong Med J; 2022 Dec; 28(6):475-481. PubMed ID: 35815480 [TBL] [Abstract][Full Text] [Related]
8. Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology. Chiu PKF; Lee EKC; Chan MTY; Chan WHC; Cheung MH; Lam MHC; Ma ESK; Poon DMC Front Oncol; 2022; 12():962958. PubMed ID: 35924163 [TBL] [Abstract][Full Text] [Related]
9. Consensus statements on the clinical usage and characteristics of aripiprazole for Hong Kong. Wong MMC; Chung AKK; Yeung TMH; Wong DTW; Lee CK; Lai E; Chan GFY; Mak GKL; Wong JOY; Ng RMK; Tam KL; Mak KY Intern Med J; 2020 Sep; 50 Suppl 3():6-14. PubMed ID: 32985093 [TBL] [Abstract][Full Text] [Related]
10. Consensus statements on adherence issues in schizophrenia for Hong Kong. Mak KY; Lo WT; Yeung WS; Wong M; Chung WS; Chui E; Tam KL; Hui LK; Mui J; Chan OW; Wong KL Asian J Psychiatr; 2014 Dec; 12():163-9. PubMed ID: 25440570 [TBL] [Abstract][Full Text] [Related]
11. Consensus statements on the clinical uses of pregabalin for Hong Kong. Kwong PP; Chan EY; Cheung EY; Fong SY; Nip W; Cheung HH; Yip IP; Chong KY; Pao RS; Tam KL; Tang MH; Chan SK; Mak KY Asia Pac Psychiatry; 2020 Sep; 12(3):e12403. PubMed ID: 32830438 [TBL] [Abstract][Full Text] [Related]
12. Guidance on the clinical understanding and use of long-acting injectable antipsychotics in Schizophrenia: Hong Kong Consensus Statements. Wong MMC; Chung AKK; Yeung TMH; Wong DTW; Lee CK; Lai E; Chan GFY; Mak GKL; Wong JOY; Ng RMK; Mak KY CNS Neurosci Ther; 2021 Mar; 27 Suppl 1(Suppl 1):5-11. PubMed ID: 33555614 [TBL] [Abstract][Full Text] [Related]
13. Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology. Poon DMC; Tan GM; Chan K; Chan MTY; Chan TW; Kan RWM; Lam MHC; Leung CLH; Wong KCW; Kam KKH; Ng CF; Chiu PKF Front Oncol; 2024; 14():1345322. PubMed ID: 38357197 [TBL] [Abstract][Full Text] [Related]
14. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Gillessen S; Attard G; Beer TM; Beltran H; Bjartell A; Bossi A; Briganti A; Bristow RG; Chi KN; Clarke N; Davis ID; de Bono J; Drake CG; Duran I; Eeles R; Efstathiou E; Evans CP; Fanti S; Feng FY; Fizazi K; Frydenberg M; Gleave M; Halabi S; Heidenreich A; Heinrich D; Higano CTS; Hofman MS; Hussain M; James N; Kanesvaran R; Kantoff P; Khauli RB; Leibowitz R; Logothetis C; Maluf F; Millman R; Morgans AK; Morris MJ; Mottet N; Mrabti H; Murphy DG; Murthy V; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Parker C; Poon DMC; Pritchard CC; Reiter RE; Roach M; Rubin M; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Shore N; Small E; Smith M; Soule H; Sternberg CN; Steuber T; Suzuki H; Sweeney C; Sydes MR; Taplin ME; Tombal B; Türkeri L; van Oort I; Zapatero A; Omlin A Eur Urol; 2020 Apr; 77(4):508-547. PubMed ID: 32001144 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer management in the era of COVID-19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro-oncology. Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Kwong PW; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Ma WK Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3(Suppl 3):48-54. PubMed ID: 33860643 [TBL] [Abstract][Full Text] [Related]
16. Management of overactive bladder: consensus statements from the Hong Kong Urological Association and the Hong Kong Geriatrics Society. Wong WKK; Kan RWM; Lam PS; Cheung PMH; Cheng EYL; Pun TCT; Tang MWS; Leung CLH; Woo SWS; Lo TK; Chu PSK; Chan TNH; Chiu PKF Hong Kong Med J; 2024 Aug; 30(4):310-319. PubMed ID: 39138142 [TBL] [Abstract][Full Text] [Related]
17. Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement. Merriel SWD; Hetherington L; Seggie A; Castle JT; Cross W; Roobol MJ; Gnanapragasam V; Moore CM; BJU Int; 2019 Jul; 124(1):47-54. PubMed ID: 30742733 [TBL] [Abstract][Full Text] [Related]
18. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong. Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX; Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017 [TBL] [Abstract][Full Text] [Related]
19. Consensus statements on the clinical understanding and use of bupropion in Hong Kong. Lee WK; Au Yeung KL; Lam HB; Wong CK; Wong TC; Fu CK; Sham SK; Au MK; Lam TC; Ki-Yan Mak D CNS Neurosci Ther; 2021 Mar; 27 Suppl 1(Suppl 1):20-24. PubMed ID: 33555615 [TBL] [Abstract][Full Text] [Related]
20. [Advanced Prostate Cancer Consensus Conference (APCCC) 2015 in St. Gallen : Critical review of the recommendations on diagnosis and therapy of metastatic prostate cancer by a German expert panel]. Thomas C; Bögemann M; König F; Machtens S; Schostak M; Steuber T; Heidenreich A Urologe A; 2016 Jun; 55(6):772-82. PubMed ID: 26820660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]